Medigene AG reports Financial Results and Business Update for Q1 2024
GlobeNewswire
*Planegg/Martinsried, **April 26, 2024.* Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology..
*Planegg/Martinsried, **April 26, 2024.* Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology..
*Ad hoc announcement pursuant to Art. 53 LR*
· Idorsia receives a positive opinion from the Committee for Medicinal..
The destruction of nature might one day become a criminal offense adjudicated by the International Criminal Court.
On..